3,690
edits
Obesity: Difference between revisions
no edit summary
No edit summary |
No edit summary |
||
| Line 37: | Line 37: | ||
Kelly AS, Auerbach P, Barrientos-Perez M, et al. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. The New England journal of medicine. May 28 2020;382(22):2117-2128. doi:10.1056/NEJMoa1916038 | Kelly AS, Auerbach P, Barrientos-Perez M, et al. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. The New England journal of medicine. May 28 2020;382(22):2117-2128. doi:10.1056/NEJMoa1916038 | ||
[https://www.nejm.org/doi/full/10.1056/NEJMoa2208601 Once-Weekly Semaglutide in Adolescents with Obesity] | |||
[https://pubmed.ncbi.nlm.nih.gov/35441470/ STEP 1 Study Group. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension] | [https://pubmed.ncbi.nlm.nih.gov/35441470/ STEP 1 Study Group. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension] | ||